No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs147639275 |
chr20:15789090-15789091 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs1008583 |
chr20:15789122-15789123 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs551034374 |
chr20:15789123-15789124 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs577643264 |
chr20:15789177-15789178 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs111804607 |
chr20:15789203-15789204 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs536614533 |
chr20:15789246-15789247 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs368585309 |
chr20:15789255-15789256 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs182892292 |
chr20:15789271-15789272 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs368357432 |
chr20:15789296-15789297 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs6135545 |
chr20:15789362-15789363 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs150082262 |
chr20:15789405-15789406 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs577364705 |
chr20:15789434-15789435 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs187225962 |
chr20:15789438-15789439 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs6131722 |
chr20:15789466-15789467 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
15 |
rs543175922 |
chr20:15789470-15789471 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs377270908 |
chr20:15789517-15789518 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs575144246 |
chr20:15789532-15789533 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs542185928 |
chr20:15789579-15789580 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs368188437 |
chr20:15789678-15789679 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs145532180 |
chr20:15789748-15789749 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs540135519 |
chr20:15789755-15789756 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs564769744 |
chr20:15789809-15789810 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs532322270 |
chr20:15789826-15789827 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs16996594 |
chr20:15789861-15789862 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs148855336 |
chr20:15790001-15790002 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs556973781 |
chr20:15790032-15790033 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs143484290 |
chr20:15790054-15790055 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs548562702 |
chr20:15790055-15790056 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs138966529 |
chr20:15790065-15790066 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs534544221 |
chr20:15790077-15790078 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs192733428 |
chr20:15790080-15790081 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs570990850 |
chr20:15790081-15790082 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs6079973 |
chr20:15790104-15790105 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs6079974 |
chr20:15790112-15790113 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs538398540 |
chr20:15790124-15790125 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs6135546 |
chr20:15790136-15790137 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
37 |
rs575251484 |
chr20:15790153-15790154 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs6135547 |
chr20:15790159-15790160 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
39 |
rs554192315 |
chr20:15790171-15790172 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs572486295 |
chr20:15790232-15790233 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs184758638 |
chr20:15790244-15790245 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs13043627 |
chr20:15790310-15790311 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs540172178 |
chr20:15790336-15790337 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs565156054 |
chr20:15790348-15790349 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs60109870 |
chr20:15790377-15790378 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs548322078 |
chr20:15790405-15790406 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|